5 Recruiting Colorectal Cancer Phase 3 Clinical Trials
Active phase 3 studies for colorectal cancer enrolling across the USA. Verify eligibility and contact site coordinators.
All Colorectal Cancer studiesPhase 3 Studies for Colorectal Cancer
🔵 Active, Not Recruiting Phase3
Study of XL092 + Atezolizumab vs Regorafenib in Participants With Metastatic Colorectal Cancer
📍 Exelixis Clinical Site #65 — Jonesboro, Alabama
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3
The Northern-European Initiative on Colorectal Cancer
📍 Harvard School of Public Health — Boston, Massachusetts
View Study & Checklist ➔ 🟢 Recruiting Phase2 / Phase3
Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)
📍 BAMF Health — Grand Rapids, Michigan
View Study & Checklist ➔ 🟢 Recruiting Phase3
A Study to Access Intravenous (IV) Telisotuzumab Adizutecan in Combination With IV Bevacizumab Compared to Standard of Care IV Bevacizumabin Combination With Oral Trifluridine and Tipiracil in Adult Participants With Refractory Metastatic Colorectal Cancer
📍 Astera Cancer Care /ID# 279532 — East Brunswick, New Jersey
View Study & Checklist ➔ 🟢 Recruiting Phase3
Study of Petosemtamab Plus Chemotherapy Versus Cetuximab or Bevacizumab Plus Chemotherapy in RAS and BRAF Wild Type, Recurrent, Unresectable or Metastatic Colorectal Cancer (LiGeR-CRC2)
📍 PanOncology — Manati,
View Study & Checklist ➔